Overview
Kaiping Luo practices practicing medicine in Changhongjie, China.
Their clinical expertise encompasses Diffuse Large B-Cell Lymphoma (DLBCL), B-Cell Lymphoma, Non-Hodgkin Lymphoma, and Squamous Cell Lung Carcinoma.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Kaiping Luo
Is Kaiping Luo a top-rated expert for Diffuse Large B-Cell Lymphoma (DLBCL)?
MediFind is an objective health platform that identifies experts based on real-world data. Kaiping Luo is classified as an Experienced expert for Diffuse Large B-Cell Lymphoma (DLBCL), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Kaiping Luo participate in research or clinical trials?
Yes. Kaiping Luo has published 10 articles and abstracts on conditions like Diffuse Large B-Cell Lymphoma (DLBCL). You can view a list of Kaiping Luo's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- B-Cell LymphomaLuo isExperienced. Learn about B-Cell Lymphoma.
- Diffuse Large B-Cell Lymphoma (DLBCL)
- Non-Hodgkin LymphomaLuo isExperienced. Learn about Non-Hodgkin Lymphoma.
- Squamous Cell Lung Carcinoma